Pega Medical’s pediatric orthopedic portfolio includes the Fassier-Duval Telescopic Intramedullary System for treating osteogenesis imperfecta and other bone deformities, according to a June 14 news release.
The deal includes an upfront cash payment of $31 million and $2 million in stock.
